Technical Analysis for KAPA - Kairos Pharma, Ltd.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 1.51 | 3.42% | 0.05 |
KAPA closed down 0.68 percent on Wednesday, November 20, 2024, on 24 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | N/A | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 3.42% | |
| Calm After Storm | Range Contraction | 3.42% | |
| NR7 | Range Contraction | 3.42% | |
| Narrow Range Bar | Range Contraction | 3.42% | |
| Stochastic Reached Oversold | Weakness | 3.42% | |
| Inside Day | Range Contraction | 3.42% | |
| Wide Bands | Range Expansion | 3.42% | |
| Oversold Stochastic | Weakness | 3.42% | |
| Fell Below 20 DMA | Bearish | 2.72% | |
| Calm After Storm | Range Contraction | 2.72% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 5 minutes ago |
| Outside Day | 5 minutes ago |
| Up 5% | 5 minutes ago |
| 20 DMA Resistance | about 3 hours ago |
| Down 5% | about 3 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Immunotherapies Drug Therapies
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Immunotherapies Drug Therapies
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.0 |
| 52 Week Low | 1.24 |
| Average Volume | 353,214 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 1.52 |
| 10-Day Moving Average | 1.66 |
| Average True Range | 0.29 |
| RSI (14) | 45.05 |
| ADX | 41.14 |
| +DI | 26.08 |
| -DI | 17.99 |
| Chandelier Exit (Long, 3 ATRs) | 1.89 |
| Chandelier Exit (Short, 3 ATRs) | 2.11 |
| Upper Bollinger Bands | 2.05 |
| Lower Bollinger Band | 0.99 |
| Percent B (%b) | 0.45 |
| BandWidth | 70.14 |
| MACD Line | 0.02 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0155 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.65 | ||||
| Resistance 3 (R3) | 1.65 | 1.59 | 1.61 | ||
| Resistance 2 (R2) | 1.59 | 1.54 | 1.59 | 1.60 | |
| Resistance 1 (R1) | 1.53 | 1.52 | 1.56 | 1.52 | 1.59 |
| Pivot Point | 1.47 | 1.47 | 1.48 | 1.47 | 1.47 |
| Support 1 (S1) | 1.40 | 1.42 | 1.44 | 1.40 | 1.33 |
| Support 2 (S2) | 1.34 | 1.39 | 1.34 | 1.32 | |
| Support 3 (S3) | 1.28 | 1.34 | 1.31 | ||
| Support 4 (S4) | 1.27 |
